Add BrightSurf on Google Email

JCI Journals


JCI online early table of contents: June 5, 2008

Researchers have identified cells that initiate infant tumors, developing a new mouse model to identify therapeutic targets. A molecule called IRF4 has been found to control inflammation in the gut, while implanting olfactory ensheathing cells promotes neuroplasticity in stroke models.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJun 5, 2008

JCI online early table of contents: June 2, 2008

A team of researchers at The Scripps Research Institute identified molecular changes in the cerebrospinal fluid of monkeys infected with SIV, which can cause CNS damage. This approach may provide new information about other neurodegenerative and neuropsychiatric disorders.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJun 2, 2008

JCI table of contents: May 22, 2008

Researchers discovered that HIV protease inhibitors can prevent photoreceptor apoptosis in mouse models of retinal detachment, reducing the cause of vision loss. CD133 expression was found not to be restricted to stem cells, and both CD133+ and CD133– metastatic colon cancer cells can initiate tumors.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMay 22, 2008

JCI online early table of contents: May 15, 2008

Researchers suggest a novel approach to reducing VEGF-induced vision loss by targeting Src kinases, offering a potential alternative to painful eye injections. Leaky Ca2+ release channels in the brain and heart may also contribute to seizures and irregular heartbeats in individuals with certain inherited disorders.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMay 15, 2008

Look to the future: New drug reduces one cause of vision loss

A new small molecule inhibitor of Src kinases was found to eliminate VEGF-induced fluid accumulation in the retina of mice and rabbits. The approach, which involved topical application or intravenous injection, showed promise for reducing vision loss due to VEGF-mediated blood vessel permeability.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMay 15, 2008

How slow growth as a fetus can cause diabetes as an adult

Research using a rat model of intrauterine growth retardation found reduced Pdx1 expression in pancreatic beta-cells throughout life following IUGR. The molecular mechanisms affecting Pdx1 expression were reversible in the fetus and after birth, but irreversible in adulthood, providing new insight into diabetes development.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMay 8, 2008

JCI online early table of contents: May 8, 2008

Researchers found that slow fetal growth is linked to an increased risk of developing type 2 diabetes in adulthood. They also identified a new gene mutation associated with sudden cardiac death in humans. The study used rat models and human tissue samples to understand the mechanisms behind these diseases.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMay 8, 2008

JCI online early table of contents: May 1, 2008

Researchers have found that tricyclic antidepressants can restore vagal function and reduce intestinal inflammation in individuals with inflammatory bowel disease, particularly those who are also depressed. Genetic mutations linked to permanent neonatal diabetes mellitus have been identified, and bacteria can blunt the responses of inv...

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMay 1, 2008

2 types of image are better than 1 for analyzing tumors

A new method developed by Murali Krishna and colleagues at the National Institutes of Health uses low-field paramagnetic resonance imaging to image tumors and surrounding organs in mice. This approach has shown promise for determining the best treatment approach for tumors and other diseases, as well as monitoring responses to treatment.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateApr 22, 2008

JCI table of contents: April 22, 2008

A new non-invasive method to determine tumor oxygen levels and image surrounding tissues has been developed, offering promising insights into tumor development. Researchers suggest that this approach could lead to improved diagnosis and treatment strategies for tumors and other diseases.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateApr 22, 2008

JCI online early table of contents: April 15, 2008

New data shows that vectors derived from AAV5 can accommodate large genes, including those missing in a mouse model of recessive Stargardt disease. This breakthrough has implications for treating individuals with the disease, which is characterized by progressive loss of sight.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateApr 15, 2008

JCI online early table of contents: April 8, 2008

Researchers discovered a molecular pathway underlying low-grade forms of brain tumor known as astrocytoma, suggesting new therapeutic targets. Additionally, studies revealed that microRNAs regulate female mouse fertility by controlling the functioning of the corpus luteum, which is essential for pregnancy.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateApr 8, 2008

Too many gene copies stimulate tumor cell growth

Researchers discovered that duplicated regions of DNA containing the BRAF gene lead to increased tumor growth. Targeting the MAPK pathway, which is downstream of BRAF, may provide a new approach for treating individuals with low-grade astrocytomas.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateApr 8, 2008

New approach to limiting organ damage in sickle cell disease

A new study found that bosentan prevents experimentally induced vaso-occlusive crises in a mouse model of SCD, reducing blood vessel resistance and preventing organ damage. Bosentan may provide a new way to limit VOCs and thereby reduce mortality and morbidity in individuals with Sickle Cell Disease.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateApr 1, 2008

JCI online early table of contents: April 1, 2008

Researchers have identified a potential mechanism for treating multiple sclerosis using IFN-beta, which reduces disease in a mouse model by inducing IL-27 secretion. Meanwhile, a new study on sickle cell disease suggests that bosentan prevents organ damage by inhibiting endothelin receptor activation. Leptin signaling also plays a cruc...

SourceJCI Journals·JournalJournal of Clinical Investigation·DateApr 1, 2008

JCI table of contents: March 20, 2008

Researchers have identified a crucial role for antibodies in protecting against nontyphoidal strains of Salmonella bacteria, which causes fatal infections in African children. Meanwhile, a study on HOXB4 gene therapy found that early precursors can cause leukemia in large animals, highlighting the need for extreme caution in human trials.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMar 20, 2008

JCI online early table of contents: March 13, 2008

Researchers found a link between high levels of adenosine and priapism in male mice with sickle cell disease. The study suggested that reducing adenosine levels or blocking its activation could provide new treatments for priapism. Additionally, two other studies explored the development of reproductive disorders in humans and the prote...

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMar 13, 2008

Pinpointing when you become a man

A study in rats reveals that the 'male' hormone-driven decision to become male occurs before genitalia development. Measuring AGD in neonates could predict reproductive disorders like cryptorchidism and low sperm count.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMar 13, 2008

JCI online early table of contents: March 6, 2008

New DNA vaccine technology targets DCs for enhanced immune response; studies in mice show improved protection against viruses and potential applications for cystic fibrosis modeling. Genetic manipulation creates large animal models of CF, providing new avenues for disease research.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMar 6, 2008

Genetic manipulation might model cystic fibrosis

Researchers at the University of Iowa and Missouri have developed pig and ferret models of cystic fibrosis through genetic manipulation. The studies used adeno-associated virus vectors to disrupt or introduce mutations into the CFTR gene, resulting in animals that may lead to the development of a good animal model for the disease.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMar 6, 2008

JCI online early table of contents: March 3, 2008

Researchers analyzed skin biopsies from patients with acne before and after 1 week of treatment with 13-cis RA, suggesting new treatments may be developed to combat severe side effects. Estradiol-binding proteins play a role in protecting against hearing loss, potentially leading to new treatments for this condition as well.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMar 3, 2008

How the drug isotretinoin zaps acne

Researchers have discovered how isotretinoin, the most potent acne treatment, works by triggering cell death in sebaceous glands. The study found that agents targeting Neutrophil gelatinase-associated lipocalin may provide a new approach to treating acne.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMar 3, 2008

JCI table of contents: Feb. 21, 2008

A study found that genetic variations in the MBL2 protein are associated with more severe clinical symptoms of cystic fibrosis. In contrast, daily administration of growth hormone increased CD4+ T cell numbers in HIV-1 infected individuals, potentially treating conditions where CD4+ T cell function is impaired.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateFeb 21, 2008

HOXA11 shows its strength in the pelvis

The study found that mice lacking HOXA11 had no uterosacral ligaments, highlighting the gene's importance in their development. In women with pelvic organ prolapse (POP), decreased HOXA11 expression was linked to weakened connective tissue and increased levels of a degradation mediator.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateFeb 14, 2008

A new look inside the brain at cerebral malaria

Researchers have developed a new method to detect activated platelets in the brain of mice with cerebral malaria, allowing for earlier diagnosis. The use of a specific single-chain antibody and iron oxide microparticles enables detection by MRI, potentially leading to improved therapeutic and diagnostic strategies.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateFeb 14, 2008

JCI online early table of contents: Feb. 14, 2008

Scientists discovered that HOXA11, a homeobox gene, is essential for the development of uterosacral ligaments, which are weakened in women with pelvic organ prolapse. In another study, researchers found that increased expression of the WNT antagonist sFRP-1 contributes to elevated intraocular pressure in glaucoma patients.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateFeb 14, 2008

JCI online early table of contents: Feb. 7, 2008

VEGF-B has been shown to inhibit apoptosis in retinal cells and brain cells in mouse models of injury and stroke, suggesting its potential as a new treatment for neurodegenerative diseases. Autophagy is also identified as a virulence-associated trait and survival mechanism for the fungal pathogen Cryptococcus neoformans.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateFeb 7, 2008

JCI online early table of contents: Feb. 1, 2008

New research reveals that timing of IL-7 treatment is crucial for enhancing antiviral immunity. Additionally, studies on cardiac development and wound healing have identified novel genes and mechanisms, offering potential therapeutic targets for chronic viral infections and cutaneous wounds.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateFeb 1, 2008

JCI table of contents: Jan. 24, 2008

A new study by Naofumi Mukaida and colleagues found that TNF-alpha antagonist reduces inflammation-induced colon cancer in mice, suggesting a potential treatment for ulcerative colitis patients. Additionally, research on mesenchymal stem cells showed that the antitumor drug bortezomib can target these cells and promote bone cell-specif...

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJan 24, 2008

Building stronger bones, 1 stem cell at a time

Researchers discovered that the antitumor drug bortezomib can specifically target mesenchymal stem cells, leading to enhanced bone regeneration in mice. Bortezomib treatment increased bone formation in normal mice and recovered bone loss in mice with induced osteoporosis.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJan 24, 2008

JCI table of contents: Jan. 17, 2008

Researchers have discovered that increasing lipid associated with apoE in the brain may decrease amyloid deposition in Alzheimer's patients. Meanwhile, a new study found that neutralizing IL-22 prevents psoriasis-like disease in mice, suggesting a potential approach to treating this chronic condition. Additionally, scientists have deve...

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJan 17, 2008